Aspirin induces erythrocyte nitric oxide synthase activity in vivo

Clinica Chimica Acta

Volumn 314, Issue 1-2, 2001, Pages 265-267

  Durak, Ilker ^a   Çimen, M Y Burak ^a   Çimen, Ö Bölgen ^b   Kaçmaz, Murat ^a   Gören, Deniz ^a   Öztürk, H Serdar ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THROMBOXANE A2; VASOCONSTRICTOR AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANALYTIC METHOD; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; HUMAN; INFECTION; INFLAMMATION; LETTER; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; BLOOD; DRUG EFFECT; ENZYMOLOGY;

ADULT; AGED; ASPIRIN; ERYTHROCYTES; FEMALE; HUMAN; MALE; MIDDLE AGE; NITRIC-OXIDE SYNTHASE;

EID: 0035166545     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00659-3     Document Type: Letter

References (6)

1. The use of aspirin in ischemic heart disease
2. Randomised trial of prophylactic daily aspirin in British male doctors
3. Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists
4. Aspirin and salicilate enhances the induction of inducible nitric oxide synthatase in cultured rat smooth muscle cells
5. Glucose 6 phosphate dehydrogenase. In red cell metabolism
6. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide